Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Slaton

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nanotechnology|November 22, 2017
Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancerNeeda A Virani, Carole Davis, Patrick McKernan, et al.
Urologic Oncology|May 3, 2021
Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancerHyun Hwan Sung, Douglas S Scherr, Joel Slaton, et al.
American Journal of Clinical and Experimental Urology|October 22, 2016
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyDavid Jarrard, Badrinath Konety, Wei Huang, et al.
Contemporary Clinical Trials|November 22, 2011
Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancerNagi Kumar, Theresa Crocker, Tiffany Smith, et al.
The New England Journal of Medicine|November 5, 2015
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, W Marston Linehan, Paul T Spellman, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nanotechnology|November 22, 2017
Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancerNeeda A Virani, Carole Davis, Patrick McKernan, et al.
Urologic Oncology|May 3, 2021
Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancerHyun Hwan Sung, Douglas S Scherr, Joel Slaton, et al.
American Journal of Clinical and Experimental Urology|October 22, 2016
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyDavid Jarrard, Badrinath Konety, Wei Huang, et al.
Contemporary Clinical Trials|November 22, 2011
Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancerNagi Kumar, Theresa Crocker, Tiffany Smith, et al.
The New England Journal of Medicine|November 5, 2015
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, W Marston Linehan, Paul T Spellman, et al.
Pageof 2